Estimaciones de analistas de Wall Street para Dare Bioscience, Inc. (DARE): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.14 | ||
| 2026-08-13 | $-0.20 | $-0.30 | +32.6% |
| 2026-05-14 | $-0.20 | $-0.33 | +39.4% |
| 2026-03-26 | $-0.02 | $-0.24 | +91.7% |
| 2025-11-13 | $-0.28 | $-0.33 | +15.2% |
| 2025-08-14 | $-0.45 | $-0.55 | +18.2% |
| 2025-05-13 | $-0.50 | $-0.63 | +20.6% |
| 2025-03-31 | $-0.64 | $-0.66 | +3.0% |
Ratios de valoración
| Precio / Valor contable | -18.96 |
| EV / EBITDA | -0.53 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $766000 | 0 | 0 | 0 | 0 | 0 | $10.0M | $2.8M | $9784 | $1.0M |
| Coste de Ventas | $400000 | 0 | $625000 | $11137 | $83333 | $100000 | $30.1M | $21.6M | $14.3M | $2.4M |
| Beneficio Bruto | $366000 | 0 | -$2440 | -$11137 | -$83333 | -$100000 | -$20.1M | -$18.8M | -$14.3M | -$1.4M |
| I+D | $27.6M | $984749 | $6.4M | $8.5M | $20.8M | $30.6M | $30.0M | $21.5M | $14.2M | $5.52B |
| Generales y Administrativos | $10.4M | $2.7M | $5.3M | $5.8M | $6.5M | $8.4M | $11.2M | $11.9M | $9.2M | $8.8M |
| Gastos Operativos | $37.9M | $3.7M | $11.7M | $14.3M | $27.3M | $39.0M | $11.2M | $12.1M | $9.2M | $12.1M |
| Beneficio Operativo | -$37.2M | -$11.2M | -$16.9M | -$14.3M | -$27.4M | -$39.1M | -$31.4M | -$30.9M | -$23.5M | -$13.6M |
| EBITDA | -$36.8M | -$11.2M | -$11.7M | -$14.3M | -$27.4M | -$38.7M | -$30.9M | -$30.7M | -$4.0M | -$10.4M |
| Gastos por Intereses | $2.2M | $322629 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $822709 |
| Beneficio Antes de Impuestos | -$39.3M | -$11.5M | -$16.7M | -$14.3M | -$27.4M | -$38.7M | -$30.9M | -$30.2M | -$4.1M | -$13.4M |
| Impuestos | $86000 | 0 | $10.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$39.3M | -$11.5M | -$16.7M | -$14.3M | -$27.4M | -$38.7M | -$30.9M | -$30.2M | -$4.1M | -$13.4M |
| BPA | $-30.02 | $-3.56 | $-30.16 | $-10.99 | $-10.93 | $-7.52 | $-4.39 | $-4.15 | $-0.48 | $-1.20 |
| BPA Diluido | $-30.02 | $-3.56 | $-30.16 | $-10.99 | $-10.93 | $-7.52 | $-4.39 | $-4.15 | $-0.48 | $-1.20 |
| Acciones en Circulación (Diluidas) | $1.3M | $269356 | $894368 | $1.3M | $2.5M | $5.1M | $7.0M | $7.3M | $8.5M | $111.8M |
Precio
| Precio | $0.73 |
| Capitalización | $11M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ADTX · AIMD · ANL · ASBP · ATHA · CTXR · FBLG
Explorar sector: Healthcare · Biotechnology
Más secciones de DARE: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones